This increased EOMES expression is in line with the known skewed phenotype of CD8+ T cells toward activation-induced dysfunction in CLL, which suggests a role for EOMES in CD8+ T-cell-mediated control of CLL progression. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.